Randomized Phase III Study of Pemetrexed + Cisplatin and Vinorelbine + Cisplatin for Completely Resected Non-squamous Non-Small Cell Lung Cancer.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 22 Sep 2016
At a glance
- Drugs Pemetrexed (Primary) ; Cisplatin; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 12 Sep 2016 Status changed from recruiting to active, no longer recruiting.
- 15 Mar 2012 Actual initiation date (Mar 2012) added as reported by University Hospital Medical Information Network - Japan.
- 15 Mar 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.